Goodwin advised OncoC4 on the deal.OncoC4 announced its agreement with BioNTech SE pursuant to which BioNTech receives an exclusive worldwide license to co-develop and commercialize OncoC4’s next-generation…
OncoC4’s Strategic Collaboration with BioNTech
